This grant is for advancing clinical treatment research into Posttraumatic Stress Disorder (PTSD) among active duty U.S. Army Soldiers. Due to high operational tempo and multiple deployments, soldiers face significant psychological challenges, with an estimated 17% experiencing deployment-related PTSD. This condition is often compounded by co-occurring behavioral health issues such as depression, substance abuse, and suicidal ideation. Current evidence-based treatments, including cognitive-behavioral therapies, EMDR, and SSRIs, are only partially effective, failing up to 50% of patients. Therefore, this grant seeks innovative research proposals aimed at developing and evaluating more effective clinical interventions to mitigate the impact of PTSD on Soldier well-being, retention, and recruitment within the Army.
Opportunity ID: 48354
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-MOMRP-PTSDTX |
| Funding Opportunity Title: | Posttraumatic Stress Disorder (PTSD) Clinical Treatment Research Amoung Active Duty Army Soldiers |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | Jul 08, 2009 |
| Original Closing Date for Applications: | Aug 05, 2009 |
| Current Closing Date for Applications: | Nov 24, 2009 |
| Archive Date: | Dec 24, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Correction of URL Link | Jul 08, 2009 | |
| Updated Title | Jul 08, 2009 | |
| Updated Title | Jul 08, 2009 | |
| Jul 08, 2009 | ||
| Correcrted Opportunity Number | Jul 08, 2009 | |
| Jul 08, 2009 |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-MOMRP-PTSDTX |
| Funding Opportunity Title: | Posttraumatic Stress Disorder (PTSD) Clinical Treatment Research Amoung Active Duty Army Soldiers |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | Jul 08, 2009 |
| Original Closing Date for Applications: | Aug 05, 2009 |
| Current Closing Date for Applications: | Nov 24, 2009 |
| Archive Date: | Dec 24, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-MOMRP-PTSDTX |
| Funding Opportunity Title: | Posttraumatic Stress Disorder (PTSD) Clinical Treatment Research Amoung Active Duty Army Soldiers |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Nov 24, 2009 |
| Archive Date: | Dec 24, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-MOMRP-PTSDTX |
| Funding Opportunity Title: | Post Traumatic Stress Disorder – PTSD |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Nov 24, 2009 |
| Archive Date: | Dec 24, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-MOMRP-PTSDTX |
| Funding Opportunity Title: | Post Traumatic Stress Disorder |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Nov 24, 2009 |
| Archive Date: | Dec 24, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-MOMRP-PTSDTX |
| Funding Opportunity Title: | Post Traumatic Stress Disorder |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 05, 2009 |
| Archive Date: | Sep 04, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-09-PTSD |
| Funding Opportunity Title: | Post Traumatic Stress Disorder |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 08, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Aug 05, 2009 |
| Archive Date: | Sep 04, 2009 |
| Estimated Total Program Funding: | $3,500,000 |
| Award Ceiling: | $3,500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | U.S. Army Soldiers are enduring unyielding high operational tempo in garrison and the combat field of operations in order to keep pace with ongoing Wartime mission requirements. The high tempo and increasingly common multiple deployments present many human physical and psychological challenges (Military Health Advisory Team IV (MHAT-IV), 2006; MHAT-V, 2008) that have a rippling effect on Soldier well-being as well as Army retention and recruitment. According to seminal work by Hoge et al. (2004), an estimated 17% of active duty Soldiers screened positive for deployment-related Posttraumatic Stress Disorder (PTSD) post deployment to Operation Iraqi Freedom or Operation Enduring Freedom (OIF/OEF); recent estimates (MHAT V, 2008) were suggested to be within the estimated ranges. PTSD is often complicated by other behavioral health problems including depression, alcohol and other drug (AOD) use, and suicide/suicide-related behavior (e.g., Seal, Bertenthal, Miner, Sen, & Marmar, 2007). All evidence-based treatments, including cognitive-behavioral based exposure therapies (Foa, Keane, & Friedman, 2000), Eye Movement Desensitization and Reprocessing (EMDR) therapy (e.g., Rothbaum, 1997; Shapiro, 2001), and selective serotonin reuptake inhibitors (SSRIs) (e.g., Brady et al., 2000), are only partially effective (Friedman, Keane, & Resick, 2007). The complicated presentation of PTSD may likely contribute to the finding that existing evidence-based treatments are up to 50% ineffective in treating PTSD symptoms. |
| Link to Additional Information: | Post Traumatic Stress Disorder Progam Announcement – W81XWH-09-PTSD |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Ethan J. Mueller
Grants Officer Phone 301-619-2192 Email:Ethan.Muller@us.army.mil |
Related Documents
Folder 48354 Full Announcement-1 -> ptsd pa_final_1july09.pdf
Packages
| Agency Contact Information: | Ethan J. Mueller Grants Officer Phone 301-619-2192 Email: Ethan.Muller@us.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| PKG00012985 | Jul 08, 2009 | Nov 24, 2009 | View |
Package 1
Mandatory forms
48354 RR_SF424-1.1.pdf
48354 RR_OtherProjectInfo-1.1.pdf
48354 RR_PerformanceSite-1.1.pdf
48354 RR_KeyPersonExpanded-1.1.pdf
48354 RR_Budget-1.1.pdf
Optional forms
48354 RR_PersonalData-1.1.pdf
48354 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
